Actively Recruiting

Phase Not Applicable
Age: 40Years - 75Years
All Genders
NCT07380880

Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neuropathy

Led by Montiha Azeem · Updated on 2026-02-03

80

Participants Needed

1

Research Sites

7 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus and is associated with sensory loss, impaired proprioception, balance deficits, and altered gait patterns, which significantly increase the risk of falls and functional dependence. Rehabilitation strategies targeting sensory and proprioceptive impairments are essential to improve postural control and mobility in this population. This randomized controlled trial aims to compare the effects of proprioceptive neuromuscular training and sensory re-education on balance and gait performance in patients with diabetic peripheral neuropathy. Participants diagnosed with DPN will be randomly allocated into two groups. Group A will receive sensory re-education, while Group B will undergo a structured proprioceptive training program. Both groups will also receive baseline conventional treatment. Balance and gait outcomes will be assessed using the Berg Balance Scale and the Dynamic Gait Index at baseline, mid-intervention, and post-intervention. The findings of this study may help determine the more effective rehabilitation approach for improving balance and gait in individuals with diabetic peripheral neuropathy, thereby reducing fall risk and enhancing functional independence.

CONDITIONS

Official Title

Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neuropathy

Who Can Participate

Age: 40Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Both males and females
  • Diagnosed with Diabetes Mellitus (Type 1 or Type 2)
  • Aged between 40-75 years
  • Presence of diabetic peripheral neuropathy confirmed by Michigan Neuropathy Assessment Tool or Toronto Clinical Rating Scale
  • HbA1c level greater than 7% consistently over the last 6 months
Not Eligible

You will not qualify if you...

  • Unable to walk independently or with assistance
  • Any history of neurological disorders
  • Any history of musculoskeletal disorders in the past 6 months
  • Renal and liver failure
  • History of ischemic heart disease
  • History of dizziness or balance-impairing conditions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shadman Medical Center

Lahore, Punjab Province, Pakistan, 54000

Actively Recruiting

Loading map...

Research Team

N

Nimra Zaheer, MSPTN

CONTACT

M

Montiha Azeem, MSPTN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here